ondansetron

FDA Drug Profile — ondansetron

ondansetron is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand name including ondansetron. Available dosage forms: injection, powder, tablet, orally disintegrating.

Drug details

Generic Name
ondansetron
Brand Names
ondansetron
Application Number
ANDA206846
Sponsor
Accord Healthcare, Inc.
NDC Codes
7
Dosage Forms
INJECTION, POWDER, TABLET, ORALLY DISINTEGRATING
Routes
INTRAMUSCULAR, INTRAVENOUS, ORAL
Active Ingredients
ONDANSETRON

Indications and Usage

1 INDICATIONS AND USAGE Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron tablets are a 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . (1) nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. (1) nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. (1) postoperative nausea and/or vomiting. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.